Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Omicron

Covid incubation period: How long are you infectious for?

Experts warn of fresh wave of infections as hospital admissions rise

The Independent UK

Nine Omicron symptoms affecting the fully vaccinated - and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

The Independent UK

Cathie Wood Trims Pfizer Stake And Loads Up $25M In Rival COVID-19 Vaccine Maker

Cathie Wood led Ark Invest on Wednesday initiated a position in Moderna Inc (NASDAQ: MRNA) after the biotech company said an updated version of its COVID-19 booster vaccine appeared to provide strong

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Mumbai: 62% Covid patients at SevenHills fully vaccinated

MUMBAI: More than 62% patients admitted to the SevenHills Hospital, Andheri for Covid-19 are fully vaccinated, indicating that majority could be affected with the Omicron variant of Sars-Cov2 that is known for its ability to evade immunity from vaccines. The high vaccine penetration, though, is perhaps the reason why most…

The Times of India

Trials of new COVID vaccine raise hopes of once-a-year booster

Moderna shot is said to produce eightfold increase in antibody levels against Omicron in first four weeks

The Guardian - UK

New omicron subvariants in California bring new questions about coronavirus outlook

The upward track of California’s coronavirus case rate may be easing, but contradictory data are muddying the state’s outlook as a new pair of omicron subvariants seen in South Africa are increasingly making appearances here.

Los Angeles Times

Moderna vaccine trial raises hopes of yearly Covid booster

People who received vaccine showed significant jump in antibody levels compared to original Moderna jab

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Concern grows as two new Omicron sub-variants spread across US

Scientists warn that BA.4 and BA.5 are more contagious forms that could escape immunity from past infections and vaccinations

The Guardian - US

Moderna’s omicron-targeted shot bolsters antibodies in trial

Moderna Inc. said its COVID-19 vaccine that targets omicron generated a “superior” immune response against the variant compared to its original shot in a widely awaited study that could pave the way for another round of boosters in the fall.

Tribune News Service

Full Truck Alliance Shares Surge On Solid Q1 Earnings, Clocks 54% Revenue Growth

Full Truck Alliance Co Ltd (NYSE:YMM) reported first-quarter revenue of RMB1.33 billion ($210.2 million), up 53.7% year-over-year. Gross Transaction Value reached RMB53.6 billion ($8.5 billion), an increase of 4.2% Y/Y. YMM fulfilled orders for Q1 reached 25.2 million, an increase of 13.6% Y/Y. Average shipper MAUs were 1.42 million, an increase of 16%…

Benzinga

Moderna's Updated COVID-19 Shot Boosts Omicron Protection

Moderna Inc (NASDAQ: MRNA) has

Benzinga

The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Moderna booster update for Omicron variant could be available late summer

The booster contains the original vaccine with an updated version that specifically targets the Omicron variant.

Axios

Moderna announces promising results from next-generation Covid vaccine trials

Experts hope the newer jabs could protect against a wider range of variants.

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

WEKU

Moderna says its new vaccine booster shows 'superior' response to omicron

The "bivalent" vaccine — meaning it targets two different antigens — is Moderna's leading candidate for an effective booster this fall. If the data pan out, it could lead to a yearly booster.

The Independent UK

Moderna says updated COVID shot boosts omicron protection

Moderna says its experimental COVID-19 vaccine that combines its original shot with protection against the omicron variant appears to work

Asharq Al-Awsat

Moderna Says Omicron-Specific Booster Generates Strong Immune Response

Moderna Inc said on Wednesday its COVID-19 vaccine booster that targets both the original coronavirus strain and Omicron produced a better immune response against the variant than its original vaccine. The booster raised virus-neutralizing antibodies by eight-fold in a study.

Reuters

Moderna says Omicron-targeted COVID shot shows better response

Moderna Inc said on Wednesday a new version of its coronavirus vaccine produced a better immune response against Omicron than the original shot, as the drugmaker pursues a booster against a surge in infections in the fall season.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Covid incubation period: How long are you infectious for?

Experts warn of fresh wave of infections as hospital admissions rise

Tribune News Service

COVID-19 still surging in California’s capital region. Will subvariants lead to even more?

A major Sacramento K-12 district has returned to indoor masking, a Bay Area county of more than 1.6 million people has reverted to a countywide mask mandate, and transmission and hospitalization rates for COVID-19 continue to swell throughout California as a new pair of omicron subvariants make up a growing…

The Times of India

80% jump in Maharashtra Covid tally, Mumbai records 1,242 cases

MUMBAI: Within a 24-hour span, the Covid tally in Maharashtra rose by over 80% with Mumbai and the satellite cities of Thane and Navi Mumbai accounting for more than 90% of Tuesday's caseload of 1,881 cases, reports Malathy Iyer.

Salon

Novavax's new shot may sway anti-vaxxers

Experts hope the new COVID vaccine, which uses older biotechnology, could help the unvaccinated come around

The Times of India

BA.2 still dominant Omicron subvariant nationwide, say experts

PUNE: Omicron's BA.2, which caused the third wave in India, remains the dominant variant of the virus in the country, top officials overseeing genomic surveillance told TOI on Monday.

WEKU

Coronavirus FAQ: I got COVID. Then I got it again. What's the deal with reinfection?

People who catch COVID may feel as if they won't get it again, at least not for a long time. Their immune system should be primed to fight it off in the future. Right? Well, let's see.

Benzinga

H.C. Wainwright Predicts Yatra Online Stock Price To Double

H.C. Wainwright & Co analyst Scott Buck maintained its Buy rating on the shares of Yatra Online Inc (NASDAQ: YTRA), with a price target of $4. The analyst said though Q4 results were negatively impacted by the Omicron variant in January, demand was at 90.0% of pre-COVID levels across both leisure and corporate travel as…

1 … 63 64 65 66

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.